Abstract
To evaluate the effect of donidalorsen, an antisense inhibitor of prekallikrein (PKK), taken every 8 weeks in patients with hereditary angioedema (HAE), a disease characterized by recurrent, disabling swellings.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
